Autoimmune Diseases  >>  Cyltezo (adalimumab-adbm)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cyltezo (adalimumab-adbm) / Boehringer Ingelheim
NCT02636907: Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe

Completed
2
77
US, Europe
BI 695501 Autoinjector, BI 695501 Prefilled syringe
Boehringer Ingelheim
Arthritis, Rheumatoid
06/16
06/17

Download Options